This website uses cookies to ensure you get the best experience on our website. Learn more

Concerns Over Johnson & Johnson Vaccine

x
  • FDA Issues New Warning For J&J Vaccine Over Rare Side Effect

    1:55

    Among the 12.8 million recipients of Johnson & Johnson’s Covid vaccine, the CDC now says federal officials have identified about 100 suspected cases of Guillain-Barré syndrome, a neurological disorder in which the body’s immune system damages nerve cells. Most people who contract Guillain-Barré recover. 
    » Subscribe to NBC News:
    » Watch more NBC video:

    NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.

    Connect with NBC News Online!
    NBC News App:
    Breaking News Alerts:
    Visit NBCNews.Com:
    Find NBC News on Facebook:
    Follow NBC News on Twitter:
    Follow NBC News on Instagram:

    #NightlyNews #Vaccine #Coronavirus

  • x
  • CDC Recommends People Not Get Johnson & Johnson Vaccine if Pfizer, Moderna Available

    2:13

    An advisory panel to the CDC said people should not get the Johnson & Johnson vaccine if the Pfizer or Moderna shots are available. The panel had a meeting on the rare but potentially life threatening blood clots linked to the Johnson & Johnson vaccine. » Subscribe to NBC News:
    » Watch more NBC video:

    NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.


    Connect with NBC News Online!
    NBC News App:
    Breaking News Alerts:
    Visit NBCNews.Com:
    Find NBC News on Facebook:
    Follow NBC News on Twitter:




    #CDC #J&J #Pfizer #covid


    CDC Recommends People Not Get Johnson & Johnson Vaccine if Pfizer, Moderna Available

  • x
  • Fauci explains Johnson & Johnson vaccine pause over blood clots

    3:31

    During a Tuesday White House press briefing, Dr. Anthony Fauci explained the Johnson & Johnson COVID-19 vaccine pause after serious blood clots were reported in six recipients.

    Read more:

    SUBSCRIBE FOR MORE VIDEOS AND NEWS



    LET’S CONNECT:
    Facebook ►
    Twitter ►
    Instagram ►

  • FDA and CDC updates warning on Johnson & Johnson booster

    3:00

    Updated warning for people with history of blood clot with low platelet levels after Johnson & Johnson dose. The FDA and CDC recommend getting booster with mRNA vaccine 2+ months after J&J dose.

    SUBSCRIBE to GMA3's YouTube page:


    VISIT GMA's homepage:


    FOLLOW GMA3:
    Facebook:
    Twitter:
    Instagram:

  • x
  • Johnson & Johnson vaccine blood clots: What is cerebral venous sinus thrombosis ?

    1:01

    The U.S. has paused the use of Johnson & Johnson’s one-shot coronavirus vaccine over concerns about bloods clots.
    In a joint statement on April 13, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were recommending a “pause” until an investigation can be completed. The FDA and CDC will examine possible links between cerebral venous sinus thrombosis (CVST) and the vaccine to determine whether the shots should still be eligible for all adults or limited to certain groups.

  • CDC Panel Recommends Lifting Pause On J&J Vaccine After Rare Blood Clots | NBC News NOW

    5:53

    An advisory committee to the CDC recommended that the Johnson & Johnson Covid-19 vaccine resume distribution after rare blood clots were reported.
    » Subscribe to NBC News:
    » Watch more NBC video:

    NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.

    Connect with NBC News Online!
    NBC News App:
    Breaking News Alerts:
    Visit NBCNews.Com:
    Find NBC News on Facebook:
    Follow NBC News on Twitter:
    Follow NBC News on Instagram:

    #CDC #Coronavirus #NBCNews

    CDC Panel Recommends Lifting Pause On J&J Vaccine After Rare Blood Clots | NBC News NOW

  • x
  • Johnson & Johnson COVID-19 Vaccine: Effectiveness, Side Effects and Differences Between Vaccines

    2:45

    Dr. Dean Blumberg, Chief of Pediatric Infectious Diseases at UC Davis Children's Hospital, explains how the new Johnson and Johnson COVID-19 vaccine works and answers common questions, including why it's different from other coronavirus vaccines, how side effects compare to Pfizer and Moderna vaccines and more.

    For the latest information and resources on COVID-19, visit
    See the latest news from UC Davis Health:

    0:00 How is the Johnson & Johnson vaccine different?
    0:25 Why is it easier to distribute?
    1:00 Is it as effective as other COVID vaccines?
    1:44 Are the side effects different?
    2:01 Why is it important to have another vaccine available?

    #JohnsonandJohnson #covid19 #vaccine #coronavirus

  • CDC raises new concerns over Johnson & Johnson vaccine

    1:28

    CNBC's Meg Tirrell reports on CDC concerns over a neurological disorder associated with the Johnson & Johnson vaccine, and whether Covid-19 booster shots will be needed. For access to live and exclusive video from CNBC subscribe to CNBC PRO:

    The Food and Drug Administration is expected to announce a new warning for Johnson & Johnson’s Covid-19 vaccine, saying the shot has been linked to a serious, but rare, autoimmune disorder, The Washington Post reported Monday, citing four unnamed sources.

    About 100 preliminary reports of Guillain-Barre syndrome have been detected after 12.8 million doses of the J&J vaccine were administered, the Centers for Disease Control and Prevention said in a statement to NBC News. Guillain-Barre is a rare neurological disorder in which the body’s immune system mistakenly attacks part of the nervous system.

    It is estimated to affect about one person in 100,000 each year, and most people eventually recover from the disorder, according to the National Institute of Neurological Disorders and Stroke.

    The cases reported after receiving the J&J shot largely occurred about two weeks after vaccination and mostly in males, many aged 50 years and older, according to the CDC. Available data do not show a similar pattern with Pfizer’s or Moderna’s vaccine, the agency said.

    U.S. regulators are expected to emphasize that the J&J vaccine is safe and that its benefits clearly outweigh the potential risks, the Post reported, citing people familiar with the situation.

    The FDA did not immediately respond to CNBC’s request for comment.

    “Reports of GBS after receipt of the J&J/Janssen COVID-19 Vaccine in the Vaccine Adverse Event Reporting System (VAERS) are rare, but do likely indicate a small possible risk of this side effect following this vaccine,” the CDC said in the statement to NBC News.

    In a statement Monday, J&J said it has been in discussions with the FDA and other regulators about the disorder.

    “The chance of having this occur is very low, and the rate of reported cases exceeds the background rate by a small degree,” the company said. “We strongly support raising awareness of the signs and symptoms of rare events to ensure they can be quickly identified and effectively treated.”

    The anticipated new warning is just the latest setback for J&J, which has suffered from production problems of its vaccine as well as public concerns about a rare, potentially life-threatening, blood clotting disorder linked to its shots.

    After its authorization in late February, the vaccine was touted as a blessing since it could be stored at refrigerator temperatures for months and takes just one dose — unlike Pfizer’s and Moderna’s, which require more complicated transportation methods and are two doses.

    More than 12 million of the J&J shots have been administered in the U.S., according to data compiled by the CDC.

    » Subscribe to CNBC TV:
    » Subscribe to CNBC:
    » Subscribe to CNBC Classic:

    Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

    The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30:

    Connect with CNBC News Online
    Get the latest news:
    Follow CNBC on LinkedIn:
    Follow CNBC News on Facebook:
    Follow CNBC News on Twitter:
    Follow CNBC News on Instagram:



    #CNBC
    #CNBCTV

  • Concerns Over Johnson & Johnson Vaccine

    1:54

    The FDA and the CDC have recommended pausing the use of Johnson & Johnson vaccine after reports of rare blood clots. What symptoms should you look for if you receive this vaccine? NBC Bay Area’s Raj Mathai talks to experts about concerns over this specific vaccine.

    Stay connected:
    Follow us on Twitter:
    Like us on Facebook:
    Follow us on Instagram:
    Add us on Snapchat @NBCBayArea

    Catch up on all the day's news:

    Download our app:
    On iOS:
    On Android:

  • x
  • Concerns over Johnson & Johnson vaccines side effects

    1:37

    There are increasing reports of dizziness and lightheadedness after getting the Johnson & Johnson COVID-19 vaccine. It's raising some concerns, and the drugmaker is responding.

  • Concern over Johnson & Johnson vaccine

    2:17

    The state health department is asking that all Michigan providers temporarily pause the administration of Johnson & Johnson vaccine based on FDA and CDC guidance.

  • Easing concern over Johnson & Johnson vaccine

    2:11

    Easing concern over Johnson & Johnson vaccine

  • US health agencies concerned over Johnson & Johnson COVID-19 vaccine

    2:21

    The FDA's Dr. Peter Marks said, What we're seeing with the Janssen (Johnson & Johnson) vaccines looks very similar to what was being seen with the AstraZeneca vaccine.

  • Concerns over Johnson & Johnson vaccine grow after rare symptoms reported

    2:23

    Of the over 6.8 million doses administered, only six have shown intense side effects of blood clots

  • Clearing up concerns over Johnson and Johnson vaccine

    2:19

    We've heard from some of you at home worried that not all of the vaccines offer the same protection.
    2 on Your Side spoke to infectious disease expert to explain.

  • Concerns Over Johnson & Johnson Shot Increase Following Reports of Blood Clots in Bay Area Man

    2:04

    UCSF reported the first case of blood clots following the Johnson & Johnson shot in a Bay Area man. The announcement comes days after nine Bay Area health officers released a statement supporting to lift the pause on the Johnson & Johnson vaccine. Thom Jensen reports.

    Stay connected:
    Follow us on Twitter:
    Like us on Facebook:
    Follow us on Instagram:
    Add us on Snapchat @NBCBayArea

    Catch up on all the day's news:

    Download our app:
    On iOS:
    On Android:

  • Catholic Church has moral concerns over Johnson and Johnson COVID-19 vaccine

    2:58

    COVID-19 vaccines are still so scarce, health experts say this is not the time to be shopping —  take whatever shot you can get.

  • Health professionals address Johnson & Johnson vaccine concerns

    1:48

    As California incorporates the Johnson & Johnson vaccine, health experts continue to dispel myths within communities of color.

  • Catholic Church has moral concerns over Johnson and Johnson COVID-19 vaccine

    3:28

    COVID-19 vaccines are still so scarce, health experts say this is not the time to be shopping —  take whatever shot you can get.

  • Black Doctors Consortium addresses concerns over Johnson and Johnson vaccine

    7:59

    Dr. Ala Stanford of the Black Doctors Consortium joined Good Day to talk about why they ceased administering the Johnson and Johnson vaccine and addressed the concerns of the public who have already received it.

    The Good Day Philadelphia team breaks down the latest local, regional and national news, along with information on business, entertainment, sports, weather, traffic and more. It's everything you need to have a good day!

    Subscribe to FOX 29:

    Watch FOX 29 live:

    More Good Day Philadelphia on YouTube:

    Download the FOX 29 News app:

    Download the FOX 29 Weather app:

    Follow FOX 29 on Facebook:

    Follow FOX 29 on Twitter:

    Follow FOX 29 on Instagram:

    Subscribe to FOX 29's newsletters:

  • x
  • J&J chief scientist on concerns over coronavirus vaccine development

    2:19

    Dr. Paul Stoffels, chief scientific officer at Johnson & Johnson, joins Squawk Box to discuss the concerns some Americans have expressed around taking a coronavirus vaccine once it is available. For access to live and exclusive video from CNBC subscribe to CNBC PRO:

    » Subscribe to CNBC TV:
    » Subscribe to CNBC:
    » Subscribe to CNBC Classic:

    Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

    Connect with CNBC News Online
    Get the latest news:
    Follow CNBC on LinkedIn:
    Follow CNBC News on Facebook:
    Follow CNBC News on Twitter:
    Follow CNBC News on Instagram:

    For info on the best credit cards go to CNBC Select:


    #CNBC
    #CNBCTV

  • Clearing up concerns over Johnson and Johnson vaccine

    1:57

    We are still getting a lot of questions about how this vaccine holds up compared to Moderna and Pfizer. 2 on Your Side spoke to an infectious disease expert today.

  • CDC recommends Pfizer and Moderna COVID vaccines over Johnson & Johnson shot

    9:51

    COVID-19 cases are surging in parts of the country as the Delta and Omicron variants spread throughout major cities and towns. The Centers for Disease Control is no longer recommending the Johnson and Johnson vaccine, due to rare blood clots. Dr. Stanley Perlman, a pediatric infectious disease specialist, joins CBSN to discuss the pandemic and vaccines.

    CBSN is CBS News’ 24/7 digital streaming news service featuring live, anchored coverage available for free across all platforms. Launched in November 2014, the service is a premier destination for breaking news and original storytelling from the deep bench of CBS News correspondents and reporters. CBSN features the top stories of the day as well as deep dives into key issues facing the nation and the world. CBSN has also expanded to launch local news streaming services in major markets across the country. CBSN is currently available on CBSNews.com and the CBS News app across more than 20 platforms, as well as the Paramount+ subscription service.

    Subscribe to the CBS News YouTube channel:
    Watch CBSN live:
    Download the CBS News app:
    Follow CBS News on Instagram:
    Like CBS News on Facebook:
    Follow CBS News on Twitter:
    Subscribe to our newsletters:
    Try Paramount+ free:

    For video licensing inquiries, contact: licensing@veritone.com

  • Expert Q&A about Johnson & Johnson vaccine concerns

    1:57

    Dr. Aileen Marty of Florida International University joined Local 10 News for a live interview about the pause of Johnson & Johnson COVID-19 vaccines over blood clot concerns.

  • Johnson & Johnson vaccine concerns

    2:45

    Johnson & Johnson vaccine concerns

  • Concerns over expiring Johnson & Johnson vaccines grow in Iowa

    1:01

    Concerns over expiring Johnson & Johnson vaccines grow in Iowa

    Subscribe to KCCI on YouTube now for more:

    Get more Des Moines news:
    Like us:
    Follow us:
    Instagram:

  • Johnson & Johnson Is ‘Still A Safe Vaccine,’ Says Dr. John Torres | TODAY

    5:54

    NBC News medical correspondent Dr. John Torres joins the 3rd Hour of TODAY and weighs in on the CDC and FDA recommendation that the U.S. pauses distribution of the Johnson & Johnson COVID-19 vaccine. “They can’t make a direct link, but they just want to make sure that link is not there,” he says. “This is a message going out to doctors more than it is going out to the general public.” He also shares what recipients of the Johnson & Johnson vaccine should know and how long he thinks the pause will last.
    » Watch TODAY All Day:
    » Subscribe to TODAY:
    » Watch the latest from TODAY:

    About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.

    Connect with TODAY Online!
    Visit TODAY's Website:
    Find TODAY on Facebook:
    Follow TODAY on Twitter:
    Follow TODAY on Instagram:
    Follow TODAY on Pinterest:

    #JohnsonAndJohnson #Vaccine #TodayShow

    Johnson & Johnson Is ‘Still A Safe Vaccine,’ Says Dr. John Torres | TODAY

  • Addressing concerns about Johnson & Johnson vaccine

    1:59

    Addressing concerns about Johnson & Johnson vaccine

  • Catholic church voices moral concerns over Johnson & Johnson vaccine, but still encourage people to

    2:06

    Church leaders say that anyone who has a choice about which vaccine to get, should choose Moderna or Pfizer over Johnson & Johnson.

  • Mobile Archdiocese leaders address moral concerns over Johnson & Johnson vaccine - NBC 15 WPMI

    2:40

    More Information:

    For more information visit NBC 15 at
    Like us on Facebook:
    Follow us on Twitter: @mynbc15
    Follow us on Instagram: @mynbc15

  • Johnson & Johnson vaccine shows promise against Delta variant, plus COVID-19 back-to-school concerns

    1:59

    #Johnson&Johnson #Deltavariant #coronavirus #backtoschool
    Yahoo Finance's Anjalee Khemlani reports the latest news on the Delta variant and the Johnson&Johnson vaccine, Anjalee also spoke with Dr. Paul Offit, Children’s Hospital of Philadelphia (CHOP) director of the Vaccine Education Center about concerns regarding COVID-19 as children get ready to return to school in the fall.
    Watch the 2021 Berkshire Hathaway Annual Shareholders Meeting on YouTube:


    Subscribe to Yahoo Finance:

    About Yahoo Finance:
    At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

    Yahoo Finance Plus: With a subscription to Yahoo Finance Plus get the tools you need to invest with confidence. Discover new opportunities with expert research and investment ideas backed by technical and fundamental analysis. Optimize your trades with advanced portfolio insights, fundamental analysis, enhanced charting, and more.
    To learn more about Yahoo Finance Plus please visit:

    Connect with Yahoo Finance:
    Get the latest news:
    Find Yahoo Finance on Facebook:
    Follow Yahoo Finance on Twitter:
    Follow Yahoo Finance on Instagram:
    Follow Cashay.com
    Follow Yahoo Finance Premium on Twitter:

  • Dartmouth-Hitchcock Health Addresses Johnson & Johnson Janssen COVID-19 Vaccine Concerns

    2:31

    Section Chief of Hematology Medicine at Dartmouth-Hitchcock Medical Center, Christopher Lowrey, MD, addresses news about the temporary pause to the administration of the Johnson & Johnson Janssen COVID-19 vaccine.

    For more information -

  • Comparing Johnson & Johnson Vaccine to Pfizer And Moderna | NBC News NOW

    3:27

    NBC News’ Erika Edwards compares and contrasts the Johnson & Johnson vaccine to those of Pfizer and Moderna, addressing concerns about efficacy rate and ingredients.
    » Subscribe to NBC News:
    » Watch more NBC video:

    NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.

    Connect with NBC News Online!
    NBC News App:
    Breaking News Alerts:
    Visit NBCNews.Com:
    Find NBC News on Facebook:
    Follow NBC News on Twitter:
    Follow NBC News on Instagram:

    #Vaccine #FactCheck #NBCNews

    Johnson & Johnson Vaccine Fact-Check: Efficacy, Contents And Side Effects | NBC News NOW

  • Johnson & Johnson vaccine delayed in Europe due to safety concerns - BBC News

    3:47

    Johnson and Johnson has delayed the rollout of its Covid vaccine in Europe after regulators in the United States called for a pause because of safety concerns.

    The vaccine is marketed under the brand name Janssen in Europe.

    Six people who'd had the vaccine in the US have developed rare and severe blood clots. It's so far been given to around seven million Americans.

    Fiona Bruce presents BBC News at Ten reporting by medical editor Fergus Walsh.

    Please subscribe HERE

    #BBCNews

  • CDC issues concerns about Johnson & Johnson vaccine

    2:51

    Jarvis Robertson has the story.

  • Making sense of Johnson & Johnson COVID vaccine messaging

    2:52

    “We still have a lot of work to do,” said Dr. Kendra Holmes, standing outside the busy vaccine clinic at Affinia Healthcare. It was mid-December, so vaccines had been widely available for most of the population for months, but the clinic sees a mix of people receiving their first and second doses of COVID-19 shots along with those there for boosters.

    “This is the best tool that we have to prevent deaths,” she said.

    The medical center is just north of downtown St. Louis and has played a key role in vaccine efforts around the city.

    “We're talking about underserved communities. There is a great deal of distrust in the medical system and a lot of miscommunication,” she said.

    Dr. Holmes admitted that confusing messaging, especially as it relates to the Johnson & Johnson vaccine, can make clearer communication difficult.

    Last spring, administration of the vaccine was put on hold due to concerns over a rare blood clot side effect. Months later, in December 2021, the CDC publicly recommended people get an mRNA shot — Pfizer or Moderna — if one is available, instead of the Johnson & Johnson, due to those blood clot concerns as well as questions over the shot's resilience against variants.

    “I think that the communication for the Johnson & Johnson blood clots left a lot to be desired and actually complicated and made people even more hesitant,” said Dr. Holmes.

    The CDC also reviewed data that showed the Johnson & Johnson shot still prevents far more hospitalizations and deaths due to COVID-19 than the blood-clot condition can cause, but according to NBC News, data also showed J&J prevents fewer hospitalizations and deaths than two doses of an mRNA vaccine.

    The safety and well-being of those who use the Johnson & Johnson vaccine continues to be our No. 1 priority,” said Dr. Mathai Mammen, Global Head of research and development, in a statement following the CDC's recommendation of Pfizer and Moderna over their shots. “We appreciate [the] discussion and look forward to working with the CDC on next steps. In addition, we strongly support education and generating awareness of rare events, such as Thrombosis with Thrombocytopenia Syndrome (TTS) and how to effectively manage it.”

    The vaccine initially showed much promise as a single-dose option with easier storage requirements. Health experts touted it as a great option for clinics in remote areas or for people with limited time and transportation. However, in October, it was announced that the shot is more effective after a second dose, and anyone who received the J&J shot was encouraged to get a second one after at least two months. NBC News reports the vast majority of initial J&J recipients have opted for Pfizer or Moderna boosters.

    Despite its push as an easy access option, Dr. Holmes said making J&J the only option would have been bad for public health.

    “We knew that would not work in this community to just provide what at the time was viewed as a lower quality product, and that is absolutely something that we want to avoid working with underserved communities,” she said.

    The Johnson & Johnson shot was granted an emergency use authorization after proving high efficacy against severe COVID-19 — but those rates were about 20% lower than protection reported by Pfizer and Moderna’s vaccines.

    More than 16 million people in the U.S. have had single shots of the Johnson & Johnson vaccine, according to the CDC, and more than 489 million doses of the Pfizer and Moderna vaccines have been administered.

    “As we learn more and more information, our goal is to make sure that the community is aware of the risks and benefits associated with a particular vaccine product,” said Dr. Fred Echols, the former acting director of the St. Louis Health Department.

    He said public health best practices involve educating people on all of their choices — and what the scientific process entails.

    Given its strong durability, the Johnson & Johnson COVID-19 vaccine remains an important choice in the U.S. for people who can’t or won’t return for multiple vaccinations or who would remain unvaccinated without an alternative to the mRNA vaccines, reads a statement from the company. The vaccine website outlines information to know to help determine who might face higher risks from the vaccine.

    Johnson & Johnson shots are still available and going into arms — and Dr. Holmes said they still might be the best option for certain people to get extra protection from COVID-19.

  • San Diego County Pauses Johnson & Johnson Vaccine Over Blood Clot Concern

    1:49

    Health officials are pressing pause on the Johnson and Johnson vaccine for COVID-19… while they investigate a possible side effect. KPBS reporter Melissa Mae talked to local officials about what it means for San Diego.

  • Controversy surrounding additional dose for J&J COVID-19 vaccine recipients

    2:44

    Dr. Jen Ashton has the latest news on a supplemental COVID-19 vaccine dose being offered for those who received the Johnson & Johnson shot.

  • New Johnson and Johnson vaccine side effects causing concern

    1:56

    Side effects from Johnson & Johnson COVID-19 vaccines have temporarily shut down clinics in several states, including one in Iowa.

    Subscribe to KCCI on YouTube now for more:

    Get more Des Moines news:
    Like us:
    Follow us:
    Instagram:

  • US suspends use of Johnson & Johnson vaccine | DW News

    4:06

    The drugmaker Johnson & Johnson says it will delay the rollout of its COVID-19 vaccine in Europe. That's after health authorities in the US moved to suspend the use of the shot, due to health concerns. More than 6.8 Million doses of the Johnson & Johnson vaccine have already been administered in the US, most with no or very mild side effects. But US health bodies are now investigating unusual blood clots that occured in six women under the age of 50. The cases appear similar to a rare clotting disorder European authorities say could be linked to the AstraZeneca vaccine.

    Subscribe:

    For more news go to:
    Follow DW on social media:
    ►Facebook:
    ►Twitter:
    ►Instagram:
    Für Videos in deutscher Sprache besuchen Sie:
    #J&J # vaccine #bloodclot

  • FDA Issues Warning About J&J Covid Vaccine

    5:29

    Jul.13 -- Dr. Amesh Adalja, Johns Hopkins Center for Health Security senior scholar, discusses the warning added to Johnson & Johnson’s Covid-19 vaccine and the potential need for a third vaccine booster dose. The Johns Hopkins Bloomberg School of Public Health is supported by Michael R. Bloomberg, founder of Bloomberg LP and Bloomberg Philanthropies.

  • New Data Released On Effectiveness Of Johnson & Johnson Vaccine

    2:45

    After Monday’s potentially game-changing announcement from Pfizer on its vaccine for kids 5 to 11, new data is just out about the effectiveness of the Johnson & Johnson vaccine and how it improves with a booster shot. NBC’s Stephanie Gosk reports for TODAY.

    » Watch TODAY All Day:
    » Subscribe to TODAY:
    » Watch the latest from TODAY:

    About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.

    Connect with TODAY Online!
    Visit TODAY's Website:
    Find TODAY on Facebook:
    Follow TODAY on Twitter:
    Follow TODAY on Instagram:
    Follow TODAY on Pinterest:

    New Data Released On Effectiveness Of Johnson & Johnson Vaccine

  • Johnson & Johnson vaccine pause worries D.C. patients

    2:34

    Federal officials from the FDA and CDC have called for a pause in the use of Johnson & Johnson's coronavirus vaccine, following serious blood clotting disorders that developed in six recipients. As a result, clinics in Washington D.C. have suspended its distribution. Read more: Subscribe to The Washington Post on YouTube:

    Follow us:
    Twitter:
    Instagram:
    Facebook:

  • Catholic church voices moral concerns over Johnson & Johnson vaccine, but still encourage people to

    54

    Church leaders say that anyone who has a choice about which vaccine to get, should choose Moderna or Pfizer over Johnson & Johnson.

  • CDC advisors say mRNA vaccines preferred over Johnson and Johnson vaccine

    3:14

    There are currently three vaccines against COVID-19 in use in the United States.

  • US calls for pause on Johnson & Johnson vaccine

    9:19

    The US Centers for Disease Control and Prevention and the US Food and Drug Administration are recommending that the United States pause the use of Johnson & Johnson's Covid-19 vaccine over six reported US cases of a rare and severe type of blood clot. The six reported cases were among more than 6.8 million doses of the Johnson & Johnson vaccine administered in the United States. All six cases occurred among women ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination, according to a joint statement from the CDC and FDA. Dr. Carlos Del Rio and CNN's Dr. Sanjay Gupta discuss the announcement.
    #CNN #News

  • Dr. Payal Kohli addresses Johnson & Johnson COVID-19 vaccine concerns | KVUE

    1:33

    Dr. Kohli said if you got the Johnson & Johnson vaccine recently and have concerns, call your doctor. She reassures that the chance of developing a blood clot after getting the shot is extremely low.

    KVUE is Austin's ABC affiliate station and has been delivering local news for Central Texans since 1971. Today it is owned by TEGNA, Inc., which reaches approximately one-third of all television households in America.

  • Johnson & Johnson COVID-19 vaccine new data

    2:31

    About 12 million Americans received the J&J vaccine and new data shows it holds up against the new delta variant.

  • Dr. Faucis advice to people who got the Johnson & Johnson vaccine

    56

    Dr. Anthony Fauci answered questions Tuesday after it was reported that six women suffered blood clots within two weeks of receiving Johnson & Johnson’s COVID-19 vaccine. “Don’t get an anxiety reaction,” Fauci cautioned people who have recently gotten the J&J vaccine, noting the chances of blood clot are “less than one in a million.” Telling symptoms include as headache, shortness of breath, or chest discomfort, he said.
    The government recommended pausing the rollout of the vaccine while the instances of blood clot are investigated. More than 6.8 million doses have been administered in the U.S.

    Stream your PBS favorites with the PBS app:
    Find more from PBS NewsHour at
    Subscribe to our YouTube channel:

    Follow us:
    Facebook:
    Twitter:
    Instagram:

    Subscribe:
    PBS NewsHour podcasts:
    Newsletters:

  • In-Depth: New study on Johnson & Johnson vaccine efficacy

    2:52

    A new study claims that the antibodies created through the Johnson & Johnson COVID-19 vaccine may not be as strong as those created by the Pfizer and Moderna vaccines. But experts say the study is no cause to rush to conclusions about the vaccine.

Shares

x

Check Also

Menu